期刊文献+

五没食子酰葡萄糖(PGG)诱导鼻咽癌细胞凋亡 被引量:2

1,2,3,4,6-penta-O-galloy-D-glucose(PGG) inducing apoptosis of nasopharyngeal carcinoma cells
下载PDF
导出
摘要 目的:探讨五没食子酰葡萄糖(PGG)诱导鼻咽癌细胞的凋亡作用。方法:PGG孵育人鼻咽癌5-8F细胞株48h后,采用倒置相差显微镜观察细胞形态;PGG孵育人鼻咽癌5-8F细胞株24h后,采用流式细胞仪分析细胞早期凋亡。结果:25,50和75μmol/L PGG孵育5-8F细胞48h后,贴壁活细胞减少,漂浮死亡细胞增多。PGG孵育24h后,细胞早期凋亡率分别为(4.00±0.56)%、(6.97±0.25)%和(10.23±0.71)%,与对照组(1.53±0.15)%比较,差异有统计学意义(P<0.05)。结论:PGG具有诱导鼻咽癌细胞凋亡的生物学作用。 Objective : To investigate the effect of 1,2,3,4,6-penta-O-galloy-D-glucose(PGG) on apoptosis of nasopharyngeal carcinoma cells. Methods: PGG was incubated with human nasopharyngeal carcinoma 5-8F cell line for 48 h, cell morphology was observed by inverted phase contrast microscope. PGG was incubated with human nasopharyngeal carcinoma 5-8F cell line for 24 h, the early apoptotic cells were analyzed by Flow Cytometry. Results. 25, 50 and 75 μmol/L PGG were respectively incubated with 5-8F cell line for 48 h, the adherent living cells reduced, floating dead cells increased. Incubated for 24 h, early apoptosis cells were (4 ± 0.56)%, (6.97 ± 0.25)% and (10.23± 0.71)% in 25, 50 and 75 μmol/L PGG groups, compared with the control group (1.53 ± 0.15)%, the difference was statistically significant (P〈0.05). Conclusion. PGG has biological effects of inducing apoptosis of nasopharyngeal carcinoma ceils.
机构地区 桂林医学院
出处 《华夏医学》 CAS 2013年第3期443-445,共3页 Acta Medicinae Sinica
基金 广西自然科学基金资助(2010GXNSFC013024) 广西教育厅科研项目资助(200911MS166) 广西中医药管理局资助项目(GZKZ09-72) 教育部回国基金资助
关键词 鼻咽癌 五没食子酰葡萄糖 凋亡 nasopharyngeal carcinoma 1,2,3,4,6-penta-O-galloy-D-glucose(PGG) apoptosis
  • 相关文献

参考文献8

  • 1Wang X, Hu C,Ying H,et al. Patterns of retropharyngeal node metastasis in nasopharyngeal carcinomaJ]. Int J Radiat Oncol Biol Phys, 2009,73 (1) : 194-201.
  • 2Jinhui Zhang, Li Li, Sung-Hoon Kim, et al. Anti-canc- er, anti-diabetic and other pharmacologic and biological activities of penta galloyl glucose[J']. Pharm Res,2009,26 (9) :2066-2093.
  • 3Cryan L M, Bazinet L, Habeshian K A, et al. l, 2,3,4,6- Penta-O-galloyl--D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2 [J]. J Med Chem, 2013,56(5) :1940-1945.
  • 4Cao Y, Evans S C, Soans E, et al. Insulin receptor signa- ling activated by penta-O-galloyl--D:-glucopyranose in- duces p53 and apoptosis in cancer cells I-J]. Apoptosis, 2011,16(9) :902-913.
  • 5Klein G, Kim J, Himmeldirk K, et al. Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa[J]. Evid Based Complement Alternat Meal,2007, 4(4).401-407.
  • 6Hu H, Lee H J, Jiang C,et al. Penta-l,2,3,4,6-O-gal- loyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer ceils in vitro and suppresses prostate xen- 9graft tumor growth in vivo[J']. Mol Cancer Ther, 2008, 7(9) :2681-2691.
  • 7石大禹,金小宝,梅寒芳,刘漫宇,朱家勇.五没食子酰基葡萄糖对卵巢癌HO-8910细胞凋亡调控基因表达与胱天蛋白酶凋亡途径的影响[J].中国药理学与毒理学杂志,2012,26(4):534-539. 被引量:4
  • 8Kwon T R, Jeong S J, Lee H J, et al. Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d- glucose-induced apoptosis in chronic myeloid leukemia K562 cells[J]. Biochem Biophys Res Commun,2012,424 (3) :530-537.

二级参考文献13

  • 1Zhang J, Li L, Kim SH, Hagerman AE, Lü J. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of pentagalloylglucose[J]. Pharm Res, 2009, 26(9):2066-2080.
  • 2Ren Y, Chen X. Distribution, bioactivities and therapeutical potentials of pentagalloylglucopyranose[J]. Curr Bioactive Compounds, 2007, 3(2):81-89.
  • 3Chen WJ, Lin JK. Induction of G1 arrest and apoptosis in human Jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins[J]. J Biol Chem, 2004, 279(14):13496-13505.
  • 4Hu H, Zhang J, Lee HJ, Kim SH, Lü J. Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1[J]. Carcinogenesis, 2009, 30(5):818-823.
  • 5Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, et al. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo[J]. Mol Cancer Ther, 2008, 7(9):2681-2691.
  • 6Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma[J]. Mol Cancer, 2006, 5:67.
  • 7Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation[J]. J Biol Chem, 2009, 284(33):21777-21781.
  • 8Philchenkov A, Zavelevich M, Kroczak TJ, Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities[J]. Exp Oncol, 2004, 26(2):82-97.
  • 9Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis[J]. Genes Dev, 1999, 13(3):239-252.
  • 10Van Waes C. Nuclear factor-kappaB in development, prevention, and therapy of cancer[J]. Clin Cancer Res, 2007, 13(4):1076-1082.

共引文献3

同被引文献19

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部